| Pharmaceutical Intermediates | Manufacture of diketene derivatives used in pharmaceuticals, pigments, and pesticides. | Technical knowhow agreements, patented technologies, and regulatory approvals provide competitive edge. | Pharmaceutical companies, pigment and pesticide manufacturers, primarily B2B domestic and international clients. | Specialized high purity diketene derivatives and unique recovery technologies. | 5 | 55 | Sale of chemical intermediates to B2B clients in pharma and allied industries. | Direct sales based on volume and contract terms; export contracts fixed quantity and price based on agreements. | Demand for quality API intermediates, regulatory certifications, and technical collaborations. | MMA, MAA, DEA, EEAA, Aralydes |
| Biotechnology Division | Production of biotechnological pharmaceutical intermediates for regulated global markets. | Regulatory approvals, proprietary biotech processes, and established export relationships. | Pharmaceutical multinational corporations, export-oriented B2B customers. | USFDA approved biotech intermediates with entry into regulated pharmaceutical markets. | 4 | 45 | Sales and long-term export supply contracts for pharmaceutical raw materials. | Long-term contracts and export sales, generally fixed pricing. | USFDA approval, expansion of biotech plant capacity, and pharmaceutical R&D demands. | Pseudoephedrine, Ephedrine |
